Financhill
Sell
35

GMAB Quote, Financials, Valuation and Earnings

Last price:
$22.16
Seasonality move :
6.65%
Day range:
$21.83 - $22.21
52-week range:
$19.85 - $32.56
Dividend yield:
0%
P/E ratio:
21.09x
P/S ratio:
5.01x
P/B ratio:
2.95x
Volume:
589.9K
Avg. volume:
1.1M
1-year change:
-32.29%
Market cap:
$14.1B
Revenue:
$2.4B
EPS (TTM):
$1.05

Earnings Data

Next earnings date for GMAB
May 08
2025
Most recent earnings per share
$0.29
Missed by $0.04
(Nov 6/2024)
Consensus Estimate
$0.33
(Nov 6/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

GMAB Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
05/08/2025 Q1 $684.3M -- -- $0.27 --
12/31/2024 Q4 $877.6M -- -- $0.39 --
11/06/2024 Q3 $819.2M $816.4M $0.29 $0.33 -$0.04
08/08/2024 Q2 $723.6M $779.7M $0.31 $0.28 $0.03
05/02/2024 Q1 $572.3M $603.5M $0.29 $0.18 $0.11
02/14/2024 Q4 $667.6M $686.8M $0.15 $0.28 -$0.13
11/07/2023 Q3 $633.2M $688.1M $0.47 $0.29 $0.17
08/03/2023 Q2 $602.1M $609.3M $0.30 $0.23 $0.07
05/10/2023 Q1 $415.6M $408.7M $0.05 $0.16 -$0.11
12/31/2022 Q4 $685.1M $706.2M $0.11 $0.34 -$0.24
11/09/2022 Q3 -- $553.3M $0.53 -- --
08/10/2022 Q2 -- $452.7M $0.41 -- --
05/11/2022 Q1 -- $319.7M $0.11 -- --
02/16/2022 Q4 -- $392.8M $0.15 -- --
11/10/2021 Q3 -- $366.2M $0.21 -- --
08/11/2021 Q2 -- $319.6M $0.08 -- --
05/05/2021 Q1 -- $256.3M $0.27 -- --
02/23/2021 Q4 -- $327.4M $0.14 -- --
11/04/2020 Q3 -- $270.8M $0.13 -- --
08/12/2020 Q2 -- $805M $0.76 -- --
05/06/2020 Q1 -- $131.7M $0.06 -- --
02/19/2020 Q4 -- $439M $0.34 -- --
11/06/2019 Q3 -- $154.9M $0.12 -- --
08/14/2019 Q2 -- $116.4M $0.02 -- --
03/31/2019 Q1 -- $89.9M $0.02 -- --
12/31/2018 Q4 -- $188.9M $0.21 -- --
09/30/2018 Q3 -- $93.3M $0.05 -- --
06/30/2018 Q2 -- $81.7M $0.07 -- --
03/31/2018 Q1 -- $112.3M $0.05 -- --
12/31/2017 Q4 -- $161M $0.20 -- --
09/30/2017 Q3 -- $51.1M -$0.00 -- --
06/30/2017 Q2 -- $114.3M $0.07 -- --
03/31/2017 Q1 -- $35.9M $0.00 -- --
12/31/2016 Q4 -- $134.5M $0.20 -- --
09/30/2016 Q3 -- $54.7M $0.05 -- --
06/30/2016 Q2 -- $53.7M $0.04 -- --
03/31/2016 Q1 -- $25.2M -$0.00 -- --
12/31/2015 Q4 -- $84.3M $0.09 -- --
09/30/2015 Q3 -- $41.4M $0.03 -- --
06/30/2015 Q2 -- $25.7M $0.00 -- --
03/31/2015 Q1 -- $16.2M $0.06 -- --

Genmab AS Earnings Questions

  • How Much did Genmab AS Generate in Revenue Last Quarter?

    Genmab AS reported $816.4M worth of top line sales in its most recent quarter.

  • Did Genmab AS Beat Earnings Last Quarter?

    Genmab AS announced earnings per share of $0.29 which represents a miss of analyst forecast a $0.33 per share.

  • Is Genmab AS Profitable?

    Genmab AS reported $776.2M that represents $1.21 per share over the last quarter.

  • What is the Analyst Consensus for Genmab AS EPS Next Year?

    Genmab AS's earnings are forecast to grow from $0.96 per share to $1.26 per share next year representing an increase of 61.21%.

  • When is Genmab AS's Earnings Date?

    Genmab AS's next earnings date is May 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will Uber Stock Recover?
Will Uber Stock Recover?

Shares of Uber Technologies (NYSE:UBER) have had a rough few…

Is ARK Next Generation Internet ETF a Good Investment?
Is ARK Next Generation Internet ETF a Good Investment?

The ARK Next Generation Internet ETF looks like a pretty…

Why Is Marvell Stock Up?
Why Is Marvell Stock Up?

Semiconductor and data infrastructure company Marvell Technology (NASDAQ:MRVL) absolutely trounced…

Stock Ideas

Sell
40
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
51
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Sell
44
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 36x

Alerts

Sell
1
IONQ alert for Jan 10

IonQ [IONQ] is up 7.07% over the past day.

Sell
47
CEG alert for Jan 10

Constellation Energy [CEG] is up 25.15% over the past day.

Sell
8
CRNX alert for Jan 10

Crinetics Pharmaceuticals [CRNX] is down 16.31% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock